Company: Cureport

Job title: president


Chair’s Opening Remarks: The Breakthrough in mRNA/DNA LNP Innovations – Low N/P ratio, Nontoxic, and High Transfection Efficiency 8:30 am

Overview of Me-Too LNPs with the conclusion that the Me-Too LNPs do not meet with the needs of rapidly developed genetic vaccines and therapeutics Share Cureport’s novel strategies of LNP innovations Compare the key differences between the novel LNP and Me-Too LNPs Share the in vitro and in vivo data of the novel LNPsRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.